---
title: "T&K: Registration of Pilocarpine Hydrochloride Eye Drops Accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247619638.md"
description: "T&K announced that its wholly-owned subsidiary Huabo Kaisheng has received the \"Acceptance Notice\" for the domestic production drug registration application for Pilocarpine Hydrochloride Eye Drops issued by the National Medical Products Administration. This drug is classified as a chemical drug category 3, with a specification of 1.25%, and the applicant is Huabo Kaisheng. Pilocarpine Hydrochloride Eye Drops can treat presbyopia in adults, and the original drug was developed by Allergan and has not yet been marketed domestically. Huabo Kaisheng is the first company in China to apply for and have the generic drug application for this product accepted"
datetime: "2025-07-08T10:28:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247619638.md)
  - [en](https://longbridge.com/en/news/247619638.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247619638.md)
---

# T&K: Registration of Pilocarpine Hydrochloride Eye Drops Accepted

T&K announced that its wholly-owned subsidiary Huabo Kaisheng has received the "Acceptance Notice" for the application for the registration and marketing authorization of the domestic production of Pilocarpine Hydrochloride Eye Drops issued by the National Medical Products Administration. This drug is classified as a chemical drug of category 3, with a specification of 1.25%, and the applicant is Huabo Kaisheng. Pilocarpine Hydrochloride Eye Drops can treat presbyopia in adults, and the original drug was developed by Allergan and has not yet been launched in the domestic market. Huabo Kaisheng is the first company in China to apply for and have accepted the generic drug listing application for this product

### Related Stocks

- [301263.CN](https://longbridge.com/en/quote/301263.CN.md)

## Related News & Research

- [Goldwind-powered Ummbila Emoyeni wind farm phase one in South Africa enters commercial operation at 155 MW](https://longbridge.com/en/news/294789404.md)
- [Foresight Group reports 110,976,200 total voting rights as of July 31](https://longbridge.com/en/news/294646947.md)
- [Sage Park’s Craftech buys Stevanato’s Balda C. Brewer injection molding unit](https://longbridge.com/en/news/294839911.md)
- [Romande Energie buys Useroles wind farm in France](https://longbridge.com/en/news/294667190.md)
- [Entropy Neurodynamics wins ethics approval for 72-patient TRP-8803 basket trial](https://longbridge.com/en/news/294837136.md)